ArticleThe New England journal of medicine2024
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.
Mark P Hamilton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
130 papers cite itlatest 60 shown
this paperpooled itcites it